Olga L. Novozhilova
Research Subjects
Olga L. Novozhilova has a total of 41 co-authors. Here are the top co-authors by number of shared publications:
- Olga V. Zhukova
Moscow Scientific and Practical Center of Dermatovenereology and Cosmetology; RUDN University
11 shared publications - Nikolay Nikolaevich Potekaev
Pirogov Russian National Research Medical University; Moscow Scientific and Practical Center of Dermatovenereology and Cosmetology
7 shared publications - Aida Guseykhanovna Gadzhigoroeva
Moscow Scientific and Practical Center of Dermatovenereology and Cosmetology; Peoples’ Friendship University of Russia named after Patrice Lumumba
3 shared publications - E. V. Tolstoguzova
Moscow Scientific and Practical Center of Dermatovenereology and Cosmetology
3 shared publications - D. Yu. Vurdov
«Central Scientific Research Institute for Healthcare Organization and Informatization» of the Ministry of Health of the Russian Federation
2 shared publications - E. P. Piterskaya
Endocrinology Research Centre
2 shared publications
Latest Publications
- Open Access
- 21 September 2026
- Published by Remedium, Ltd. in Meditsinskiy sovet = Medical Council
- No. 13,p. 352-358
Artificial intelligence as a clinical decision support tool in the diagnosis and treatment of inflammatory dermatoses
Artificial intelligence (AI) in dermatovenereology has, in recent years, evolved from an experimental concept into an effective tool for clinical decision support. Modern algorithms demonstrate high diagnostic accuracy in the recognition of skin neoplasms and inflammatory dermatoses, and their use by physicians improves the sensitivity and specificity of diagnosis. AI is actively applied in the analysis of clinical images, teledermatology, confocal microscopy, and histological studies, enabling more objective assessment of skin lesions and monitoring of disease dynamics. AI is of particular importance in the management of patients with allergic dermatoses, where the clinical presentation is often complicated by secondary infection. Clinical decision support systems can detect microsigns of inflammation, assess the risks of bacterial and fungal complications, and recommend preventive therapeutic approaches. This facilitates earlier and more justified use of combination topical therapy. Combination preparations containing glucocorticosteroids, an antibiotic, and an antifungal agent allow simultaneous control of inflammation and the infectious component. The use of such agents as Akriderm GK demonstrates high clinical efficacy and rapid achievement of remission. The integration of AI into clinical practice improves diagnostic accuracy, accelerates therapeutic decision-making, and reduces the risk of complications. At the same time, the key role in decision-making remains with the physician, while AI serves as an adjunct tool that enhances clinical reasoning and improves the quality of medical care.
- 21 September 2026
- Published by Remedium, Ltd. in Meditsinskiy sovet = Medical Council
- No. 13,p. 352-358
Open AccessArtificial intelligence as a clinical decision support tool in the diagnosis and treatment of inflammatory dermatoses
Artificial intelligence (AI) in dermatovenereology has, in recent years, evolved from an experimental concept into an effective tool for clinical decision support. Modern algorithms demonstrate high diagnostic accuracy in the recognition of skin neoplasms and inflammatory dermatoses, and their use by physicians improves the sensitivity and specificity of diagnosis. AI is actively applied in the analysis of clinical images, teledermatology, confocal microscopy, and histological studies, enabling more objective assessment of skin lesions and monitoring of disease dynamics. AI is of particular importance in the management of patients with allergic dermatoses, where the clinical presentation is often complicated by secondary infection. Clinical decision support systems can detect microsigns of inflammation, assess the risks of bacterial and fungal complications, and recommend preventive therapeutic approaches. This facilitates earlier and more justified use of combination topical therapy. Combination preparations containing glucocorticosteroids, an antibiotic, and an antifungal agent allow simultaneous control of inflammation and the infectious component. The use of such agents as Akriderm GK demonstrates high clinical efficacy and rapid achievement of remission. The integration of AI into clinical practice improves diagnostic accuracy, accelerates therapeutic decision-making, and reduces the risk of complications. At the same time, the key role in decision-making remains with the physician, while AI serves as an adjunct tool that enhances clinical reasoning and improves the quality of medical care.
- 3 July 2026
- Published by Media Sphere Publishing Group in Russian Journal of Clinical Dermatology and Venereology
- Vol. 25 (3)
Epidemiology of vitiligo in the Russian Federation: national data on the prevalence and regional variability (2024)
Vitiligo is a chronic autoimmune disease characterized by skin depigmentation due to a complex interaction of genetic predisposition, oxidative stress, impaired melanocyte adhesion and dysregulated immune response. Despite its significant impact on quality of life, large-scale epidemiological data on the incidence and prevalence of vitiligo have been lacking in the Russian Federation to date. The study objective is to perform the first national epidemiological monitoring of vitiligo among children and adults in the Russian Federation in 2024. Based on the data obtained from 81 constituent entities of the Russian Federation, it was established that the registered prevalence is 15.4 cases per 100 000 in adults and 36.0 cases per 100 000 in children, which is significantly lower than global estimates (0.36—0.67%). A pronounced regional heterogeneity was revealed: from 2.6 cases (Kaliningrad region) to 56.3 cases (Yamalo-Nenets Autonomous Area) per 100 000 in adults. In Moscow, a steady increase in the incidence (from 3.48 to 7.22 cases per 100 000 in 2019—2024) and a predominance of men among adult patients are noted — a tendency that is atypical for global practice. The findings likely indicate underreporting of cases in national statistics and emphasize the need for standardized epidemiological monitoring in order to improve diagnosis, treatment and social support for patients with vitiligo in Russia.
- 3 July 2026
- Published by Media Sphere Publishing Group in Russian Journal of Clinical Dermatology and Venereology
- Vol. 25 (3)
Epidemiology of vitiligo in the Russian Federation: national data on the prevalence and regional variability (2024)
Vitiligo is a chronic autoimmune disease characterized by skin depigmentation due to a complex interaction of genetic predisposition, oxidative stress, impaired melanocyte adhesion and dysregulated immune response. Despite its significant impact on quality of life, large-scale epidemiological data on the incidence and prevalence of vitiligo have been lacking in the Russian Federation to date. The study objective is to perform the first national epidemiological monitoring of vitiligo among children and adults in the Russian Federation in 2024. Based on the data obtained from 81 constituent entities of the Russian Federation, it was established that the registered prevalence is 15.4 cases per 100 000 in adults and 36.0 cases per 100 000 in children, which is significantly lower than global estimates (0.36—0.67%). A pronounced regional heterogeneity was revealed: from 2.6 cases (Kaliningrad region) to 56.3 cases (Yamalo-Nenets Autonomous Area) per 100 000 in adults. In Moscow, a steady increase in the incidence (from 3.48 to 7.22 cases per 100 000 in 2019—2024) and a predominance of men among adult patients are noted — a tendency that is atypical for global practice. The findings likely indicate underreporting of cases in national statistics and emphasize the need for standardized epidemiological monitoring in order to improve diagnosis, treatment and social support for patients with vitiligo in Russia.
- 3 July 2026
- Published by Media Sphere Publishing Group in Russian Journal of Clinical Dermatology and Venereology
- Vol. 25 (3)
Analysis of epidemiological tendencies of syphilitic infection in the current geopolitical realities in the Russian Federation
Introduction. Syphilis is a systemic infection, primarily transmitted sexually, characterized by multiple organ and system lesions. The incidence of syphilis remains high worldwide. Objective. To analyze the dynamics of syphilis incidence as well as the composition of cases in the Russian Federation from 2014 to 2024. Materials and methods. An analysis of federal statistical monitoring data on syphilis incidence in the Russian Federation from 2014 to 2024 was performed. Results. Significant changes in syphilis incidence in the Russian Federation were identified. After a decline in the incidence rate to 10.5 cases per 100 000 population in 2020, an increase in the incidence of syphilis, most significant in the Central, Northwestern and Siberian Federal Districts, was noted by 2022. Increase in migration flows and growth in the population’s demand for medical care after levelling of the medical, social and economic consequences of COVID-19 in 2021—2022 were one of the reasons for the rise in syphilis incidence in the Russian Federation. A significant contribution to the increase in the incidence of syphilis is made by the adult urban population, especially residents of big cities. In Moscow, the vast majority of syphilis cases are detected among foreign citizens, who account for the largest increase in syphilis detection. In presence of a renewed tendency to a decrease in the incidence of syphilis in the Russian Federation as a whole up to 2024, an increase in the incidence of syphilis among adolescents is observed. In recent years, there has been a decrease in the proportion of early forms of syphilis along with an increase in the number of cases of late syphilis. Conclusion. The identified tendencies in syphilis incidence in the Russian Federation emphasize the need for further improvement of organizational measures to prevent the spread of syphilis aimed at strengthening primary and secondary prophylaxis of the disease.
- 3 July 2026
- Published by Media Sphere Publishing Group in Russian Journal of Clinical Dermatology and Venereology
- Vol. 25 (3)
Analysis of epidemiological tendencies of syphilitic infection in the current geopolitical realities in the Russian Federation
Introduction. Syphilis is a systemic infection, primarily transmitted sexually, characterized by multiple organ and system lesions. The incidence of syphilis remains high worldwide. Objective. To analyze the dynamics of syphilis incidence as well as the composition of cases in the Russian Federation from 2014 to 2024. Materials and methods. An analysis of federal statistical monitoring data on syphilis incidence in the Russian Federation from 2014 to 2024 was performed. Results. Significant changes in syphilis incidence in the Russian Federation were identified. After a decline in the incidence rate to 10.5 cases per 100 000 population in 2020, an increase in the incidence of syphilis, most significant in the Central, Northwestern and Siberian Federal Districts, was noted by 2022. Increase in migration flows and growth in the population’s demand for medical care after levelling of the medical, social and economic consequences of COVID-19 in 2021—2022 were one of the reasons for the rise in syphilis incidence in the Russian Federation. A significant contribution to the increase in the incidence of syphilis is made by the adult urban population, especially residents of big cities. In Moscow, the vast majority of syphilis cases are detected among foreign citizens, who account for the largest increase in syphilis detection. In presence of a renewed tendency to a decrease in the incidence of syphilis in the Russian Federation as a whole up to 2024, an increase in the incidence of syphilis among adolescents is observed. In recent years, there has been a decrease in the proportion of early forms of syphilis along with an increase in the number of cases of late syphilis. Conclusion. The identified tendencies in syphilis incidence in the Russian Federation emphasize the need for further improvement of organizational measures to prevent the spread of syphilis aimed at strengthening primary and secondary prophylaxis of the disease.
- 30 April 2026
- Published by Media Sphere Publishing Group in Russian Journal of Clinical Dermatology and Venereology
- Vol. 25 (2) , 169-177
Alopecia areata morbidity structure considering the association with atopic dermatitis in the population of Moscow in comparison with data from the federal register
Background. Alopecia areata (AA) is an autoimmune disease in which association with atopic dermatitis (AD) is one of the prognostically adverse factors. The relevance of studying the structure of AA morbidity taking into account atopic comorbidity is caused by the lack of modern epidemiological data and age differences in clinical manifestations. Objective. To study the structure of AA morbidity in the population of Moscow and the federal register with emphasis on association with AD. Material and methods. A multicenter retrospective cohort study was carried out on the basis of data from the Moscow Scientific and Practical Center of Dermatovenereology and Cosmetology (MSPCDC) and the register of adult patients with AA for 2020—2024. The analysis included stratification according to ICD-10 (L63.0—L63.8), age groups (children aged 0—17 years and adults aged 18 years and older), assessment of association with AD (L20.8), calculation of extensive and intensive indicators (per 100 000 population). Methods of descriptive and analytical statistics were used: logistic regression, χ² and Mann—Whitney U tests, Bonferroni correction. Results. Prevalence of local forms (L63.8—84.9%) with a steady increase in their proportion (+3.2 p.p., p<0.001) especially among children (+8.6 p.p.) was revealed. Severe forms (L63.0—L63.2) amounted to 15.1%, more frequently occurring in children (15.2% versus 12.6%, p<0.05), especially ophiasis (1.7 times more frequent, p=0.013). Association with AD was noted in 2.7% of patients with maximum increase in children (+2.2 p.p., p=0.013). For comorbidity with AD, alopecia totalis (18.2% versus 8.1% in the overall group, OR 2.47, p<0.001) and universalis (7.4% versus 3.0%, OR 2.41, p=0.003) predominated. In the register (n=403), AD was diagnosed in 15.9% of patients predominantly with alopecia universalis (27.9%, OR 4.2, p<0.001). Conclusion. The significant association of severe forms of AA with AD emphasizes the importance of considering the atopic background in assessing the clinical course of alopecia.
- 30 April 2026
- Published by Media Sphere Publishing Group in Russian Journal of Clinical Dermatology and Venereology
- Vol. 25 (2) , 169-177
Alopecia areata morbidity structure considering the association with atopic dermatitis in the population of Moscow in comparison with data from the federal register
Background. Alopecia areata (AA) is an autoimmune disease in which association with atopic dermatitis (AD) is one of the prognostically adverse factors. The relevance of studying the structure of AA morbidity taking into account atopic comorbidity is caused by the lack of modern epidemiological data and age differences in clinical manifestations. Objective. To study the structure of AA morbidity in the population of Moscow and the federal register with emphasis on association with AD. Material and methods. A multicenter retrospective cohort study was carried out on the basis of data from the Moscow Scientific and Practical Center of Dermatovenereology and Cosmetology (MSPCDC) and the register of adult patients with AA for 2020—2024. The analysis included stratification according to ICD-10 (L63.0—L63.8), age groups (children aged 0—17 years and adults aged 18 years and older), assessment of association with AD (L20.8), calculation of extensive and intensive indicators (per 100 000 population). Methods of descriptive and analytical statistics were used: logistic regression, χ² and Mann—Whitney U tests, Bonferroni correction. Results. Prevalence of local forms (L63.8—84.9%) with a steady increase in their proportion (+3.2 p.p., p<0.001) especially among children (+8.6 p.p.) was revealed. Severe forms (L63.0—L63.2) amounted to 15.1%, more frequently occurring in children (15.2% versus 12.6%, p<0.05), especially ophiasis (1.7 times more frequent, p=0.013). Association with AD was noted in 2.7% of patients with maximum increase in children (+2.2 p.p., p=0.013). For comorbidity with AD, alopecia totalis (18.2% versus 8.1% in the overall group, OR 2.47, p<0.001) and universalis (7.4% versus 3.0%, OR 2.41, p=0.003) predominated. In the register (n=403), AD was diagnosed in 15.9% of patients predominantly with alopecia universalis (27.9%, OR 4.2, p<0.001). Conclusion. The significant association of severe forms of AA with AD emphasizes the importance of considering the atopic background in assessing the clinical course of alopecia.
- 16 April 2026
- Published by Remedium, Ltd. in Meditsinskiy sovet = Medical Council
- No. 2,p. 64-68
Revisiting the epidemiology of acne in Moscow
Acne affects over 9% of the global population. The overall peak incidence occurs among ages 15 to 20. Acne also occurs in adults and has its own unique characteristics. In adolescents, the disease is triggered by hormonal factors involved in puberty, while in adults, it is caused by abnormal hormonal fluctuations. Antibiotics have been traditionally prescribed as treatments for acne, but due to the increasing antibiotic resistance in recent years, acne treatment regimens have changed. In particular, the use of antimicrobial drugs has declined, while the prescription of both topical and systemic retinoids has increased. This article reviewed epidemiological data on the prevalence of acne in Moscow over the past three years. The analysis of 289 outpatient medical records of acne patients who visited Yugo-Zapadny Branch in 2024 showed that female patients prevailed (59.9% vs 40.1%). The following disease severity distribution was reported: 241 patients with mild acne (83.4%), 43 with moderate acne (14.9%), and 5 with severe acne (1.7%). Severe acne was more common among male patients, while milder forms were more common among female patients. The incidence of acne across all age groups from 2022 to 2024 increased as follows: +15% among children (under 14 years), +31% among adolescents (15–17 years), and + 12% among adults (18 years and older). Patients over 18 years of age most often seek consultative assistance from highly specialized doctors. Acne treatment typically suggests prescription of topical retinoids, topical antibiotics, and their combinations with benzoyl peroxide for mild cases, and systemic retinoids for severe cases. The authors’ own experience allows us to recommend a 1% clindamycin solution, as well as a fixed combination of 1% clindamycin and 5% benzoyl peroxide in gel form for the treatment of mild acne, and for more severe forms as part of combination therapy
- 16 April 2026
- Published by Remedium, Ltd. in Meditsinskiy sovet = Medical Council
- No. 2,p. 64-68
Revisiting the epidemiology of acne in Moscow
Acne affects over 9% of the global population. The overall peak incidence occurs among ages 15 to 20. Acne also occurs in adults and has its own unique characteristics. In adolescents, the disease is triggered by hormonal factors involved in puberty, while in adults, it is caused by abnormal hormonal fluctuations. Antibiotics have been traditionally prescribed as treatments for acne, but due to the increasing antibiotic resistance in recent years, acne treatment regimens have changed. In particular, the use of antimicrobial drugs has declined, while the prescription of both topical and systemic retinoids has increased. This article reviewed epidemiological data on the prevalence of acne in Moscow over the past three years. The analysis of 289 outpatient medical records of acne patients who visited Yugo-Zapadny Branch in 2024 showed that female patients prevailed (59.9% vs 40.1%). The following disease severity distribution was reported: 241 patients with mild acne (83.4%), 43 with moderate acne (14.9%), and 5 with severe acne (1.7%). Severe acne was more common among male patients, while milder forms were more common among female patients. The incidence of acne across all age groups from 2022 to 2024 increased as follows: +15% among children (under 14 years), +31% among adolescents (15–17 years), and + 12% among adults (18 years and older). Patients over 18 years of age most often seek consultative assistance from highly specialized doctors. Acne treatment typically suggests prescription of topical retinoids, topical antibiotics, and their combinations with benzoyl peroxide for mild cases, and systemic retinoids for severe cases. The authors’ own experience allows us to recommend a 1% clindamycin solution, as well as a fixed combination of 1% clindamycin and 5% benzoyl peroxide in gel form for the treatment of mild acne, and for more severe forms as part of combination therapy
- 16 March 2026
- Published by Media Sphere Publishing Group in Russian Journal of Clinical Dermatology and Venereology
- Vol. 25 (1) , 53-62
Analysis of the use of GEBD in a group of patients with psoriasis (according to the data from the Moscow Scientific and Practical Center of Dermatovenereology and Cosmetology of the Moscow Healthcare Department)
Psoriasis and psoriatic arthritis are chronic immune-mediated diseases with a high risk of comorbid conditions, for which the use of genetically engineered biological drugs (GEBD) is the most effective modern approach. Choice of the optimal drug requires considering clinical and demographic factors, treatment line and presence of concomitant diseases. Material and methods. A retrospective analysis of data from 405 patients (268 men, 137 women; mean age 46.7 years) with psoriasis vulgaris (43%) and arthropathic psoriasis (57%) who were receiving GEBD was performed. The distribution by drugs, frequency of efficacy «escape», influence of therapy line and comorbid pathology was evaluated. Statistical processing included the calculation of relative values, medians, interquartile range and correlation analysis. Results. Netakimab was the most frequently prescribed agent (45.4%) with a minimum frequency of therapy «escape» effect equal 12.8%. Among the used classes of drugs, inhibitors of IL-23 (10.3%) and IL-17 (25.3%) had the most stable positive effect; at the same time, TNF-α inhibitors showed the highest frequency of loss of effect (54.9%). The first line of therapy had a median response of 93.0%, which decreased by 2—6 p.p. to the 3rd—4th lines. Metabolic syndrome (40.1%) and cardiovascular diseases (32.1%) were associated with lower response to therapy, especially in application of TNF inhibitors. The IL-17 and IL-23 inhibitors showed stable efficacy even in late administration and in patients with comorbid pathology. Discussion. The obtained results confirm the need for a personalized selection of GEBD considering the diagnosis, line of therapy and profile of comorbid pathology. Drug classes of IL-23 and IL-17 inhibitors are preferred in late lines and in patients with high cardiometabolic risk. Conclusion. The implementation of a stratified approach to the choice of GEBD and early selection of the most effective drug can reduce the risk of «escape» effect and improve long-term treatment results.
- 16 March 2026
- Published by Media Sphere Publishing Group in Russian Journal of Clinical Dermatology and Venereology
- Vol. 25 (1) , 53-62
Analysis of the use of GEBD in a group of patients with psoriasis (according to the data from the Moscow Scientific and Practical Center of Dermatovenereology and Cosmetology of the Moscow Healthcare Department)
Psoriasis and psoriatic arthritis are chronic immune-mediated diseases with a high risk of comorbid conditions, for which the use of genetically engineered biological drugs (GEBD) is the most effective modern approach. Choice of the optimal drug requires considering clinical and demographic factors, treatment line and presence of concomitant diseases. Material and methods. A retrospective analysis of data from 405 patients (268 men, 137 women; mean age 46.7 years) with psoriasis vulgaris (43%) and arthropathic psoriasis (57%) who were receiving GEBD was performed. The distribution by drugs, frequency of efficacy «escape», influence of therapy line and comorbid pathology was evaluated. Statistical processing included the calculation of relative values, medians, interquartile range and correlation analysis. Results. Netakimab was the most frequently prescribed agent (45.4%) with a minimum frequency of therapy «escape» effect equal 12.8%. Among the used classes of drugs, inhibitors of IL-23 (10.3%) and IL-17 (25.3%) had the most stable positive effect; at the same time, TNF-α inhibitors showed the highest frequency of loss of effect (54.9%). The first line of therapy had a median response of 93.0%, which decreased by 2—6 p.p. to the 3rd—4th lines. Metabolic syndrome (40.1%) and cardiovascular diseases (32.1%) were associated with lower response to therapy, especially in application of TNF inhibitors. The IL-17 and IL-23 inhibitors showed stable efficacy even in late administration and in patients with comorbid pathology. Discussion. The obtained results confirm the need for a personalized selection of GEBD considering the diagnosis, line of therapy and profile of comorbid pathology. Drug classes of IL-23 and IL-17 inhibitors are preferred in late lines and in patients with high cardiometabolic risk. Conclusion. The implementation of a stratified approach to the choice of GEBD and early selection of the most effective drug can reduce the risk of «escape» effect and improve long-term treatment results.
- Open Access
- 30 September 2025
- Published by Remedium, Ltd. in Meditsinskiy sovet = Medical Council
- No. 14,p. 212-223
Epidemiology of alopecia areata and its association with atopic dermatitis: A comparative analysis of data from the Moscow Center of Dermatovenereology and Cosmetology and the Federal Registry
Introduction. One of the frequent comorbid conditions in alopecia areata is atopic dermatitis. Existing epidemiological data on alopecia areata and its association with atopic dermatitis remain contradictory and insufficiently studied, which underscores the relevance of this research.Aim. To study the epidemiological characteristics of alopecia areata in Moscow and its association with atopic dermatitis based on population and registry data.Materials and methods. A multicenter retrospective cohort study was conducted by analyzing medical records of patients diagnosed with alopecia areata and atopic dermatitis monitored at the Moscow Center for Dermatovenereology and Cosmetology from 2020 to 2024. Federal statistics (Form No. 12), outpatient records (No. 025/u-04), and a specialized alopecia areata registry were used. Rates per 100 000 population were calculated.Results. Significant differences in alopecia areata epidemiology were found (p < 0.001): prevalence in children (36.8/100 000) was 2.7 times higher than in adults (13.7/100 000), incidence – 22.2 vs. 7.9/100 000/year. Overall morbidity increased by +83.3%, prevalence by +62.6% (p < 0.001). The association between alopecia areata and atopic dermatitis was significant (p < 0.001): overall frequency 2.66% (95% CI: 2.37–2.95), higher in children (4.09%; OR = 8.3, 95% CI: 7.1–9.7) than adults (1.85%; OR = 14.1, 95% CI: 11.9–16.7). The highest increase occurred in 2021. In the adult alopecia areata registry, atopic dermatitis was present in 15.9% (64/403).Conclusions. The significant age-dependent association between alopecia areata and atopic dermatitis confirms atopic dermatitis as an established risk factor. Registry data provide more accurate information on comorbidities. The results justify screening for atopy in alopecia areata patients and the need for a multidisciplinary management approach.
- 30 September 2025
- Published by Remedium, Ltd. in Meditsinskiy sovet = Medical Council
- No. 14,p. 212-223
Open AccessEpidemiology of alopecia areata and its association with atopic dermatitis: A comparative analysis of data from the Moscow Center of Dermatovenereology and Cosmetology and the Federal Registry
Introduction. One of the frequent comorbid conditions in alopecia areata is atopic dermatitis. Existing epidemiological data on alopecia areata and its association with atopic dermatitis remain contradictory and insufficiently studied, which underscores the relevance of this research.Aim. To study the epidemiological characteristics of alopecia areata in Moscow and its association with atopic dermatitis based on population and registry data.Materials and methods. A multicenter retrospective cohort study was conducted by analyzing medical records of patients diagnosed with alopecia areata and atopic dermatitis monitored at the Moscow Center for Dermatovenereology and Cosmetology from 2020 to 2024. Federal statistics (Form No. 12), outpatient records (No. 025/u-04), and a specialized alopecia areata registry were used. Rates per 100 000 population were calculated.Results. Significant differences in alopecia areata epidemiology were found (p < 0.001): prevalence in children (36.8/100 000) was 2.7 times higher than in adults (13.7/100 000), incidence – 22.2 vs. 7.9/100 000/year. Overall morbidity increased by +83.3%, prevalence by +62.6% (p < 0.001). The association between alopecia areata and atopic dermatitis was significant (p < 0.001): overall frequency 2.66% (95% CI: 2.37–2.95), higher in children (4.09%; OR = 8.3, 95% CI: 7.1–9.7) than adults (1.85%; OR = 14.1, 95% CI: 11.9–16.7). The highest increase occurred in 2021. In the adult alopecia areata registry, atopic dermatitis was present in 15.9% (64/403).Conclusions. The significant age-dependent association between alopecia areata and atopic dermatitis confirms atopic dermatitis as an established risk factor. Registry data provide more accurate information on comorbidities. The results justify screening for atopy in alopecia areata patients and the need for a multidisciplinary management approach.
- Open Access
- 15 April 2024
- Published by Farmarus Print Media in Russian Journal of Allergy
- Vol. 21 (1) , 74-81
Clinical and epidemiological features of cutaneous mastocytosis among the pediatric population of Moscow
BACKGROUND: Cutaneous mastocytosis is a rare disease that primarily develops in childhood. AIM: This study aimed to determine the clinical and epidemiological characteristics and frequency of detection of cutaneous mastocytosis among children in Moscow. MATERIALS AND METHODS: A single-center epidemiological retrospective study was conducted. Data from Form № 12 of the federal statistical observation "Information on the number of diseases registered in patients living in the service area of a medical organization" were used as a statistical source of information. To calculate the incidence rate in intensive indicators per 100 thousand population, data on the population of Moscow for the period 2019–2022 were used. RESULTS: Over the period 2019–2022, a gradual trend towards an increase in the number of newly identified cases of cutaneous mastocytosis in children and adolescents in Moscow was revealed. Number of initial applications from children and adolescents (0–17 years old) for this period increased by 4.8 times. The share of cutaneous mastocytosis in the structure of skin diseases and congenital anomalies (malformations) of the skin increases every year. In 2019, for every 1,834 pediatric visits (age category 0–17 years) regarding skin diseases, there was 1 case of mastocytosis; in 2020 the ratio was 1,863:1; in 2021 ― 491:1; in 2022 ― 376:1. Since 2019, there has been an increase in the primary incidence of cutaneous mastocytosis from 3.63 cases per 100,000 child population to 16.61 cases per 100,000 child population in 2022. CONCLUSION: The increase in incidence in the pediatric population and the share of cutaneous mastocytosis in the structure of skin diseases in recent years demonstrates the need to generate interest and attention of the medical community to this pathology.
- 15 April 2024
- Published by Farmarus Print Media in Russian Journal of Allergy
- Vol. 21 (1) , 74-81
Open AccessClinical and epidemiological features of cutaneous mastocytosis among the pediatric population of Moscow
BACKGROUND: Cutaneous mastocytosis is a rare disease that primarily develops in childhood. AIM: This study aimed to determine the clinical and epidemiological characteristics and frequency of detection of cutaneous mastocytosis among children in Moscow. MATERIALS AND METHODS: A single-center epidemiological retrospective study was conducted. Data from Form № 12 of the federal statistical observation "Information on the number of diseases registered in patients living in the service area of a medical organization" were used as a statistical source of information. To calculate the incidence rate in intensive indicators per 100 thousand population, data on the population of Moscow for the period 2019–2022 were used. RESULTS: Over the period 2019–2022, a gradual trend towards an increase in the number of newly identified cases of cutaneous mastocytosis in children and adolescents in Moscow was revealed. Number of initial applications from children and adolescents (0–17 years old) for this period increased by 4.8 times. The share of cutaneous mastocytosis in the structure of skin diseases and congenital anomalies (malformations) of the skin increases every year. In 2019, for every 1,834 pediatric visits (age category 0–17 years) regarding skin diseases, there was 1 case of mastocytosis; in 2020 the ratio was 1,863:1; in 2021 ― 491:1; in 2022 ― 376:1. Since 2019, there has been an increase in the primary incidence of cutaneous mastocytosis from 3.63 cases per 100,000 child population to 16.61 cases per 100,000 child population in 2022. CONCLUSION: The increase in incidence in the pediatric population and the share of cutaneous mastocytosis in the structure of skin diseases in recent years demonstrates the need to generate interest and attention of the medical community to this pathology.
- 13 April 2023
- Published by Media Sphere Publishing Group in Russian Journal of Clinical Dermatology and Venereology
- Vol. 22 (2)
Sebaceous nevus of Jadassohn associated with basal cell skin carcinoma
The paper addresses the sebaceous nevus of Jadassohn, which is a congenital defect of pilosebaceous units with the occurrence of hamartomas with their possible transformation in post-pubertal age into secondary tumors, including malignant ones. The nevus development goes through three stages, associated with hormonal changes during puberty due to the increased concentration of androgen receptors in the nevus tissue. The features of clinical, dermatoscopic, and histological diagnosis of sebaceous nevus in different age periods are described. In adults (third stage), the most important histological signs are hyperplastic sebaceous glands without excretory ducts, underdevelopment of hair follicles, dermal papillomatosis, and acanthosis of the epidermis. Dermatoscopy shows yellow, white, and/or orange globules, the size of which increases with age; also, light or dark yellow structureless areas may appear. We present three cases demonstrating the possibility of the occurrence of basal cell skin carcinoma in subjects over 40 years of age with a congenital sebaceous nevus.
- 13 April 2023
- Published by Media Sphere Publishing Group in Russian Journal of Clinical Dermatology and Venereology
- Vol. 22 (2)
Sebaceous nevus of Jadassohn associated with basal cell skin carcinoma
The paper addresses the sebaceous nevus of Jadassohn, which is a congenital defect of pilosebaceous units with the occurrence of hamartomas with their possible transformation in post-pubertal age into secondary tumors, including malignant ones. The nevus development goes through three stages, associated with hormonal changes during puberty due to the increased concentration of androgen receptors in the nevus tissue. The features of clinical, dermatoscopic, and histological diagnosis of sebaceous nevus in different age periods are described. In adults (third stage), the most important histological signs are hyperplastic sebaceous glands without excretory ducts, underdevelopment of hair follicles, dermal papillomatosis, and acanthosis of the epidermis. Dermatoscopy shows yellow, white, and/or orange globules, the size of which increases with age; also, light or dark yellow structureless areas may appear. We present three cases demonstrating the possibility of the occurrence of basal cell skin carcinoma in subjects over 40 years of age with a congenital sebaceous nevus.
- 1 January 2022
- Published by Media Sphere Publishing Group in Russian Journal of Clinical Dermatology and Venereology
- Vol. 21 (6)
Implementation of the organizational model for the prevention of malignant skin neoplasms in Moscow
В статье затронуты вопросы оказания дерматоонкологической помощи населению Москвы. Предложены организационная модель оказания этого вида помощи и схема маршрутизации пациентов с новообразованиями кожи, включающая на первом этапе кабинет профилактики злокачественных новообразований кожи (ЗНК), на втором этапе — Центр неинвазивной диагностики кожи, а в случае невозможности исключить злокачественную природу опухоли — специализированное онкологическое учреждение (третий этап) Департамента здравоохранения Москвы (ДЗМ). В рамках реализации данной модели на базе МНПЦДК организована работа по обучению врачей-терапевтов правилам проведения обследования кожных покровов пациентов в целях выявления онкологических заболеваний кожи, включая дерматоскопию, в рамках медицинских осмотров и диспансеризации взрослого населения. Для врачей-дерматовенерологов кабинетов профилактики ЗНК на регулярной основе стали проводить образовательные вебинары по повышению их квалификации по дерматоонкологии; очные практические семинары «Основы дерматоскопии». Проанализирован трехлетний опыт функционирования данной модели, свидетельствующий о ее высокой эффективности: ЗНК исключены у 314,6 тыс. человек, или 85% всех обратившихся в кабинеты профилактики ЗНК. Высокая результативность работы дерматологов позволила избежать перегрузки специализированных онкологических учреждений непрофильными больными, способствуя повышению эффективности их работы. Полученный положительный опыт и разработанная модель оказания дерматоонкологической помощи могут быть масштабированы и на другие регионы России.
- 1 January 2022
- Published by Media Sphere Publishing Group in Russian Journal of Clinical Dermatology and Venereology
- Vol. 21 (6)
Implementation of the organizational model for the prevention of malignant skin neoplasms in Moscow
В статье затронуты вопросы оказания дерматоонкологической помощи населению Москвы. Предложены организационная модель оказания этого вида помощи и схема маршрутизации пациентов с новообразованиями кожи, включающая на первом этапе кабинет профилактики злокачественных новообразований кожи (ЗНК), на втором этапе — Центр неинвазивной диагностики кожи, а в случае невозможности исключить злокачественную природу опухоли — специализированное онкологическое учреждение (третий этап) Департамента здравоохранения Москвы (ДЗМ). В рамках реализации данной модели на базе МНПЦДК организована работа по обучению врачей-терапевтов правилам проведения обследования кожных покровов пациентов в целях выявления онкологических заболеваний кожи, включая дерматоскопию, в рамках медицинских осмотров и диспансеризации взрослого населения. Для врачей-дерматовенерологов кабинетов профилактики ЗНК на регулярной основе стали проводить образовательные вебинары по повышению их квалификации по дерматоонкологии; очные практические семинары «Основы дерматоскопии». Проанализирован трехлетний опыт функционирования данной модели, свидетельствующий о ее высокой эффективности: ЗНК исключены у 314,6 тыс. человек, или 85% всех обратившихся в кабинеты профилактики ЗНК. Высокая результативность работы дерматологов позволила избежать перегрузки специализированных онкологических учреждений непрофильными больными, способствуя повышению эффективности их работы. Полученный положительный опыт и разработанная модель оказания дерматоонкологической помощи могут быть масштабированы и на другие регионы России.